WELCOME TO THIS SITE ABOUT BLUE-LIGHT CYSTOSCOPY
Here you can learn more about:
Photocure aims to develop this page to provide you with the information you need to learn about our procedure and guide you to useful patient resources.
Information for the patient
Hexvix® 85 mg powder and solvent for solution
Generic name: Hexaminolevulinate
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have further questions, please ask your doctor or nurse.
- If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
- What Hexvix® is and what it is used for
- What you need to know before you are given Hexvix®
- How to use Hexvix®
- Possible side effects
- How to store Hexvix®
- Contents of the pack and other information
1. What Hexvix® is and what it is used for
This medicine is for diagnostic use only.
This medicine is used to help identify bladder cancers. It is given before your doctor uses a special device called a ‘cystoscope’ to look inside of your bladder. A cystoscope helps to see possible tumours and thereby removing abnormal cells, which illuminate in blue light after the administration of Hexvix®.
2. What you need to know before you are given Hexvix®
- If you are allergic (hypersensitive) to the active ingredient, or any other ingredients of Hexvix®, including the liquid used to dissolve it (see Section 6 Further Information).
- If you have ‘porphyria’ (a rare inherited blood disease).
Warnings and precautions
Check with your doctor before having Hexvix®:
- If you have a urinary infection or burning feeling when you pass urine.
- If you have had BCG therapy on your bladder recently.
- If you have had an operation on your bladder recently.
These conditions may cause local reactions in your bladder, which can make it more difficult for your doctor to interpret what he sees during the examination.
Taking other medicines
Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may become pregnant or are planning to have a baby, ask your doctor for advice before having this medicine.
Driving and using machines
Talk to your doctor for advice about driving or using machines after having Hexvix®.
3. How to use Hexvix®
Hexvix® will be prepared and given to you by a specially trained and qualified person.
- Hexvix® is usually given in a hospital or clinic.
Your doctor will give it to you in the way described below:
- A small tube called a ‘catheter’ will be placed into your bladder.
- Your bladder will be emptied through this tube.
- Hexvix® will be put into your bladder through the tube.
- Hexvix® will be kept inside your bladder for about 60 minutes.
- Your bladder will then be emptied through the tube.
- The doctor will use a device-(cystoscope) to look inside of your bladder.
If you are given more Hexvix® than you should
If Hexvix® is kept in your bladder for more than 60 minutes or more Hexvix® than usual is used, no side effects are expected. If you are concerned about this, speak to your doctor or nurse.
4. Possible side effects
Like all medicines, Hexvix® can cause side effects, although not everybody gets them. There is a risk of side effects related to the examination technique (cystoscopy) used to look inside of your bladder. The use of Hexvix® as a supportive procedure to standard cystoscopy for a more accurate diagnosis of your bladder cancer is in general well tolerated. If side effects happen, they are those typically associated with the standard examination technique, they are not usually serious and do not last very long. The following side effects may happen after the examination procedure using this medicine:
(affects 1 to 10 users in 100):
- Feeling sick (nausea), vomiting.
- Muscle cramp or pain in and around your stomach area (abdomen).
- Pain and difficulty passing urine.
- Feeling unable to empty your bladder fully (urinary retention).
- Blood in your urine.
- Pain after the examination (procedure).
- Fever (high temperature).
(affects 1 to 10 users in 1,000):
- Burning feeling when you pass urine (caused by inflammation or infection of your bladder).
- Needing to pass urine more often.
- Blood poisoning (septicaemia).
- Not being able to sleep or difficulty going to sleep.
- Pain in the tube called the ‘urethra’ that urine passes through.
- Feeling like you need to pass urine right away (urgency).
- Higher levels of white blood cells, increased levels of bilirubin (this is the yellowish pigment in your bile) or increased liver enzymes, these would all be seen in blood test results.
- Lower levels of red blood cells (anaemia).
- Inflammation of the head of the penis (balanitis)
- Back pain
Frequency not known
- Anaphylactoid shock (blood pressure drop, increased heart rate, skin rash)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Hexvix®
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton. The expiry date refers to the last day of that month.
Powder and solvent: The product does not require any special storage conditions.
Solution (after mixing): Store at 2°C – 8°C (in a refrigerator) for not longer than 2 hours.
Hospital staff will ensure that the product is stored and disposed of correctly and not used after the expiry date stated on the outer carton.
6. Contents of the pack and other information
What Hexvix® contains
- The active substance is hexaminolevulinate hydrochloride.
- The other ingredients are disodium phosphate dihydrate, potassium dihydrogen phosphate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections.
What Hexvix® looks like and contents of the pack
- Each pack consists of a vial of white to off-white or pale yellow powder containing 85 mg of the active substance, hexaminolevulinate, and a prefilled syringe with or without a Mini-Spike transfer device, containing 50 ml clear, colorless liquid to dissolve the powder.
- Hexvix® powder is dissolved in the 50 ml solution provided in the pack. Once the powder and the solvent are mixed, a solution is made containing 1.7 mg/ml hexaminolevulinate, which corresponds to a 8 mmol/l solution of hexaminolevulinate.
Marketing Authorisation Holder
National authorization holders.
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
This medicinal product is authorised under the trade name Hexvix® in the following member states of the EEA: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, United Kingdom.
This leaflet was last revised 2 January 2019
Bladder Cancer is a serious diagnosis, but luckily there are many institutions and organizations who share their knowledge and resources to help the patients in their everyday life and to make the right decisions. Below we have gathered a list of resources that Photocure recommends.
National Cancer Institute
e Medicine health
Bladder Cancer Advocacy Network
Urology Care Foundation
Guy’s and St. Thomas’
Den gule bloggen